ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 152 filers reported holding ARCUS BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 3.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,411,534 | +311.0% | 78,637 | +317.7% | 0.04% | +288.9% |
| Q1 2023 | $343,404 | -33.8% | 18,827 | -24.9% | 0.01% | -40.0% |
| Q4 2022 | $518,468 | +149.3% | 25,071 | +206.1% | 0.02% | +66.7% |
| Q2 2022 | $208,000 | +3.0% | 8,190 | +13.9% | 0.01% | -52.6% |
| Q1 2021 | $202,000 | -42.1% | 7,189 | -46.5% | 0.02% | -48.6% |
| Q4 2020 | $349,000 | -61.4% | 13,425 | -74.5% | 0.04% | -36.2% |
| Q3 2020 | $903,000 | +24.4% | 52,676 | +79.5% | 0.06% | +16.0% |
| Q2 2020 | $726,000 | +98.9% | 29,349 | +11.6% | 0.05% | +92.3% |
| Q1 2020 | $365,000 | +78.9% | 26,309 | +60.8% | 0.03% | +85.7% |
| Q1 2019 | $204,000 | – | 16,361 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |